ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/24/2026
Back to search
Official data from USPTO
MESOBLAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MESOBLAST
ST13
US500000086008550Class
5, 42
Filing
86008550
Registration
4494438
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
03/25/2026
Trademark type
Word
Nice classes
5, 42
Filing date
07/12/2013
Registration date
03/11/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2024
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Melbourne, AU
Examiner
LOVELACE, JAMES B
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mesoblast Limited
Mesoblast Limited
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; veterinary preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; biotechnology preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; medical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluidscultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantationmedical and surgical purposes but not including embryonic stem cells; human cells including stem cells for medical or clinical use but not embryonic stem cells; animal cells including stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatmentreconstruction and repair of tissue but not including preparations for embryonic stem cells
Class 42
Scientificmedical researchclinical researchpharmaceutical research and developmentadvisory and consultancy services in the field of T-cell productionT-cell immunotherapycell culture devicestissue engineering for cellular applications for humans and animalsstem cell bankingtissue bankingdrug discoveryvaccine screeningcell culture methodscell expansion technology including stem cell expansion technologycellular therapies including stem cell therapies and cellular transplants; none of the aforementioned services relating to embryonic stem cells
Publications
History of USPTO decisions and trademark events.
28 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/20/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/20/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/20/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/11/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/11/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/05/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/05/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2020
E815
TEAS SECTION 8 & 15 RECEIVED
03/11/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/11/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/25/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/25/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2013
PUBO
PUBLISHED FOR OPPOSITION
12/24/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/19/2013
ALIE
ASSIGNED TO LIE
11/19/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/29/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
10/29/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/29/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
10/29/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/29/2013
DOCK
ASSIGNED TO EXAMINER
10/25/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2013
NWAP
NEW APPLICATION ENTERED
07/16/2013
Continuous trademark protection
Get notified about every new filing that threatens MESOBLAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.